Wasabi-Derived 6-(Methylsulfinyl)Hexyl Isothiocyanate Induces Apoptosis in Human Breast Cancer by Possible Involvement of the NF-κB Pathways

REFERENCES

• Lim JM, Amin A, Trushin N, and Hecht SS: Effect of isothiocyanates on tumorigenesis by benzo[a]pyrane in murine tumor models. Cancer Lett 74, 151–159, 1993.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kensler TW, Cho CG, Posner GH, and Talalay P: Anticarcinogenic activities of sulforaphane and structurally related synthetic norbonyl isothiocyanates. Proc Natl Acad Sci USA 91, 3147–3150, 1994.
   PubMed Web of Science ®Google Scholar
• Fuke Y, Haga Y, Ono H, Nomura T, and Ryoyama K: Anti-carcinogenic activity of 6-methylsulfinylhexyl isothiocyanates (6-MITC), and an active antiproliferative principal of wasabi (Eutrema wasabi Maxim.). Cytotechnology 25, 197–203, 1997.
   PubMed Web of Science ®Google Scholar
• Yano T, Yajima S, Virgona N, Yano Y, Otani S, et al.: The effect of 6-methylthiohexyl isothiocyanate isolated from Wasabi japonica (wasabi) on 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in mice. Cancer Lett 155, 115–120, 2000.
   PubMed Web of Science ®Google Scholar
• Ono H, Adachi K, Fuke Y, and Shinohara K: Purification and structural analysis of substances in wasabi (Eutrema wasabi Maxim.) that suppress the growth of MKN-28 human stomach cancer cells. J Japn Food Sci Technol 43, 1092–1097, 1996.
   Web of Science ®Google Scholar
• Hou De-Xing, Fukuda M, Fujii M, and Fuke Y: Transcriptional regulation of nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase in murine hepatoma cells by 6-(methylsulfinyl)hexyl isothiocyanate, an active principle of wasabi (Eutrema wasabi Maxim). Cancer Letters 161, 195–200, 2000.
   PubMed Web of Science ®Google Scholar
• Nomura T, Shinoda S, Yamori T, Sawaki S, Nagata I, et al.: Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro. Cancer Detection and Prevention 29, 155–160, 2005.
   PubMedGoogle Scholar
• Fuke Y, Sawaki S, Nagata I, Higashi N, Nomura T, et al.: 6-(methylsulfinyl)hexyl isothiocyanate isolated from wasabi (Wasabia japonica Matsum) suppresses the tumor metastasis in an experimental mouse system. Food Science and Technology Research 9, 148–151, 2003.
   Web of Science ®Google Scholar
• Fuke Y, Shinoda S, Nagata I, Sawaki S, Murata M, et al.: Preventive effect of oral administration of 6-MITC derived from wasabi against pulmonary metastasis of B16-BL6 mouse melanoma cells. Cancer Detection & Prevention 30, 174–179, 2006.
   PubMedGoogle Scholar
• Tsujimoto Y: Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195, 158–167, 2003.
   PubMed Web of Science ®Google Scholar
• Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 15, 2922–2933, 2001.
   PubMed Web of Science ®Google Scholar
• Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, et al.: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43–50, 1998.
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Török L, Ellinger A, et al.: Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett 82–83, 143–148, 1995.
   PubMed Web of Science ®Google Scholar
• Pledgie-Tracy A, Sobolewski MD, and Davidson NE: Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 6, 1013–1021, 2007.
   PubMed Web of Science ®Google Scholar
• Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, et al.: Apoptosis caused by chemotherapeutic inhibition of nuclear factor-κB activation. Cancer Res 63, 290–295, 2003.
   PubMed Web of Science ®Google Scholar
• Karin M and Lin A: NF-κ B at the crossroads of life and death. Nat Immunol 3, 221–227, 2002.
   PubMed Web of Science ®Google Scholar
• Biswas DK, Shi Q, Bailey S, Strickland I, Ghosh S, et al.: NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101, 10137–10142, 2004.
   PubMed Web of Science ®Google Scholar
• Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, et al.: The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5, 119–127, 1999.
   PubMed Web of Science ®Google Scholar
• Wang CY, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS: NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation. Science 281, 1680–1683, 1998.
   PubMed Web of Science ®Google Scholar
• Angel P and Karin M: The role of Jun. Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072, 129–157, 1991.
   PubMed Web of Science ®Google Scholar
• Prasad S, Ravindran J, and Aggarwal BB: NF-κB and cancer: how intimate is this relationship. Mol Cell Biochem 336, 25–37, 2010.
   PubMed Web of Science ®Google Scholar
• Biswas DK, Shi Q, Bailey S, Strickland I, Ghosh S, et al.: NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101, 10137–10142, 2004.
   PubMed Web of Science ®Google Scholar
• Newton TR, Patel NM, Bhat-Nakshatri P, Stauss CR, Goulet RJ Jr, et al.: Negative regulation of transactivation function but not DNA binding of NF-κB and AP-1 by IκBβ1 in breast cancer cells. J Biol Chem 274, 18827–18835, 1999.
   PubMed Web of Science ®Google Scholar
• Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, et al.: Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide. Oncogene 19, 4159–4169, 2000.
   PubMed Web of Science ®Google Scholar
• Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, et al.: The nuclear factor κB (NF-κ B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci USA 98, 10386–10391, 2001.
   PubMed Web of Science ®Google Scholar
• RJ Jr: NF-κB and breast cancer. Curr Probl Cancer 26, 282–309, 2002.
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, and Li ZW: NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2, 301–310, 2002.
   PubMed Web of Science ®Google Scholar
• Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells. Br J Cancer 90, 2370–2377, 2004.
   PubMed Web of Science ®Google Scholar
• Biswas DK, Shi Q, Bailey S, et al.: NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101, 10137–10142, 2004.
   PubMed Web of Science ®Google Scholar
• Nomura T, Uehara Y, Kawajiri H, Ryoyama K, Yamori T et al.: Alkyl isothiocyanates suppress epidermal growth factor receptor kinase activity but augment tyrosine kinase activity. Cancer Epidemiology 33, 288–292, 2009.
   PubMed Web of Science ®Google Scholar
• Xu C, Shen G, Chen C, Gélinas C, and Kong AN: Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24, 4486–4495, 2005.
   PubMed Web of Science ®Google Scholar
• Karin M and Lin A: NF-κB at the crossroads of life and death. Nat Immunol 3, 221–227, 2002.
   PubMed Web of Science ®Google Scholar
• Saijo K, Mecklenbräuker I, Schmedt C, and Tarakhovsky A: B cell immunity regulated by the protein kinase C family. Ann N Y Acad Sci 987, 125–134, 2003.
   PubMed Web of Science ®Google Scholar
• Mut M, Amos S, and Hussaini IM: PKC α phosphorylates cytosolic NF-κB/p65 and PKC delta delays nuclear translocation of NF-κB/p65 in U1242 glioblastoma cells. Turk Neurosurg 20, 277–285, 2010.
   PubMed Web of Science ®Google Scholar